Douglas, Raymond, MD, Phd

Jan 24, 2020 | Investigator Profiles

Raymond Douglas, M.D., Ph.D.

Dr. Raymond Douglas is an experienced and board-certified oculoplastic surgeon based in Beverly Hills, CA. Additionally, he recently opened a practice in Shanghai, China. His expertise includes treating thyroid-associated eye diseases and cosmetic and reconstruction surgeries. 

 

Dr. Douglas was one of two co-principal investigators of the phase 3 OPTIC trial, a multi-center international clinical trial (23 centers), the data of which were used by the U.S. FDA as the basis for approving Tepezza (teprotumumab) as a new treatment for thyroid eye disease (TED). The FDA approval of Tepezza was granted in January of 2020. The results from the trial were recently published in the New England Journal of Medicine. He also co-founded the International Thyroid Eye Disease Society to formulate international trials.

 

Currently, Dr. Douglas is the Director of the Orbital and Thyroid Eye Disease program at the prestigious Cedars-Sinai Medical Center in Los Angeles. He has held positions at the UCLA School of Medicine, Harbor-UCLA Medical Center, Greater Los Angeles Veterans Hospital, Veterans Administration Ann Arbor Healthcare System, and the University of Michigan Kellogg Eye Center.

 

Dr. Douglas graduated with academic distinction from the University of Pennsylvania and began his medical training at the University of Pennsylvania. He then completed a sub-specialized fellowship in Orbital Facial Plastic and Reconstructive Surgery at the UCLA Jules Stein Eye Institute.

Dr. Douglas was one of two co-principal investigators of the phase 3 OPTIC trial, a multi-center international clinical trial (23 centers), the data of which were used by the U.S. FDA as the basis for approving Tepezza (teprotumumab) as a new treatment for thyroid eye disease (TED). The FDA approval of Tepezza was granted in January of 2020. The results from the trial were recently published in the New England Journal of Medicine. He also co-founded the International Thyroid Eye Disease Society to formulate international trials.

Currently, Dr. Douglas is the Director of the Orbital and Thyroid Eye Disease program at the prestigious Cedars-Sinai Medical Center in Los Angeles. He has held positions at the UCLA School of Medicine, Harbor-UCLA Medical Center, Greater Los Angeles Veterans Hospital, Veterans Administration Ann Arbor Healthcare System, and the University of Michigan Kellogg Eye Center.

Dr. Douglas graduated with academic distinction from the University of Pennsylvania and began his medical training at the University of Pennsylvania. He then completed a sub-specialized fellowship in Orbital Facial Plastic and Reconstructive Surgery at the UCLA Jules Stein Eye Institute.

Associated Articles

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

0 Comments

Pin It on Pinterest